Estimated Brain Age in Healthy Aging and Across Multiple Neurological Disorders
Li Chai,Jun Sun,Zhizheng Zhuo,Ren Wei,Xiaolu Xu,Yunyun Duan,Decai Tian,Yutong Bai,Ningnannan Zhang,Haiqing Li,Yuxin Li,Yongmei Li,Fuqing Zhou,Jun Xu,James H. Cole,Frederik Barkhof,Jianguo Zhang,Huaguang Zheng,Yaou Liu
DOI: https://doi.org/10.1002/jmri.29667
IF: 4.4
2024-11-28
Journal of Magnetic Resonance Imaging
Abstract:Background The brain aging in the general population and patients with neurological disorders is not well understood. Purpose To characterize brain aging in the above conditions and its clinical relevance. Study Type Retrospective. Population A total of 2913 healthy controls (HC), with 1395 females; 331 multiple sclerosis (MS); 189 neuromyelitis optica spectrum disorder (NMOSD); 239 Alzheimer's disease (AD); 244 Parkinson's disease (PD); and 338 cerebral small vessel disease (cSVD). Field Strength/Sequence 3.0 T/Three‐dimensional (3D) T1‐weighted images. Assessment The brain age was estimated by our previously developed model, using a 3D convolutional neural network trained on 9794 3D T1‐weighted images of healthy individuals. Brain age gap (BAG), the difference between chronological age and estimated brain age, was calculated to represent accelerated and resilient brain conditions. We compared MRI metrics between individuals with accelerated (BAG ≥ 5 years) and resilient brain age (BAG ≤ −5 years) in HC, and correlated BAG with MRI metrics, and cognitive and physical measures across neurological disorders. Statistical Tests Student's t test, Wilcoxon test, chi‐square test or Fisher's exact test, and correlation analysis. P
radiology, nuclear medicine & medical imaging